20:04 , Apr 25, 2019 |  BC Innovations  |  Finance

The academic founders' conundrum

First-time academic entrepreneurs face a circular problem: while they’re continually sought after by VCs and pharmas seeking the next “big thing”, they also face an arduous path to establish their bona fides - not for...
17:08 , Apr 6, 2018 |  BC Week In Review  |  Financial News

CMAB raises $34M for manufacturing upgrade

CMAB Biopharma Inc. (Suzhou, China) raised $34 million on April 2 in a series B round led by new investor CD Capital. Also participating were C-Bridge Capital, Cormorant, Qianhai FoF Fund and Tigermed. CMAB, a...
16:21 , Apr 2, 2018 |  BC Extra  |  Financial News

CMAB raises $34M for manufacturing upgrade

CMAB Biopharma Inc. (Suzhou, China) raised $34 million in a series B round led by new investor CD Capital. Also participating were C-Bridge Capital, Cormorant, Qianhai FoF Fund and Tigermed. CMAB said it will upgrade...
19:08 , Jan 19, 2018 |  BioCentury  |  Finance

Incubating in China

C-Bridge Capital is one of the newer venture funds in Chinese healthcare seeking to bring mature platforms or programs from the Western market into China. Compared with most other Chinese VCs, however, C-Bridge is investing...
21:18 , Jan 5, 2018 |  BC Week In Review  |  Financial News

CMAB raises $38M series A

CMAB Biopharma Inc. (Suzhou, China) raised $38 million on Jan. 2 in a series A round led by C-Bridge Capital and BioBay. I-Bridge Capital and Qianhai FoF fund also participated. The contract development and manufacturing...
16:47 , Jan 2, 2018 |  BC Extra  |  Financial News

CMAB raises $38M series A

CMAB Biopharma Inc. (Suzhou, China) raised $38 million in a series A round led by C-Bridge Capital and BioBay. I-Bridge Capital and Qianhai FoF fund also participated. The contract development and manufacturing organization follows global...
07:00 , Aug 24, 2015 |  BC Week In Review  |  Company News

BeiGene cancer news

BeiGene said it is establishing a biomanufacturing facility in BioBay , an innovation hub located in the Suzhou Industrial Park of Suzhou, China. It expects the cGMP facility to be completed by 2017. BeiGene said...
01:09 , Aug 21, 2015 |  BC Extra  |  Company News

BeiGene expands into BioBay

BeiGene Ltd. (Beijing, China) said it is establishing a biomanufacturing facility in BioBay , an innovation hub located in the Suzhou Industrial Park of Suzhou, China. It expects the facility to be completed by 2017....
08:00 , Nov 3, 2014 |  BC Week In Review  |  Company News

J&J pharmaceuticals news

Johnson & Johnson launched its Asia-Pacific Innovation Center, the fourth of J&J's centers. Located in Shanghai with satellite offices in Singapore, Australia and Japan, the center will identify early stage innovations in the areas of...
08:00 , Nov 3, 2014 |  BioCentury  |  Strategy

Translation in Asia

The low concentration of entrepreneurs and venture money in the Asia-Pacific region means Johnson & Johnson 's newest innovation center will initially go about making early stage deals and investments differently than its counterparts in...